Client Context
A U.S.-based biotechnology company was preparing to launch a patented pharmaceutical product that required fresh lemon as a critical raw material. As the project moved from development to industrial-scale production, the client needed a reliable, scalable, and compliant procurement strategy to ensure uninterrupted supply.
Given the agricultural nature of the input, the sourcing landscape was exposed to seasonality, price volatility, quality variation, and regulatory complexity. The client engaged Kepler Ventures to assess the U.S. lemon supply chain and design a robust procurement roadmap suitable for pharmaceutical-grade production.
The Challenge
The client faced multiple structural and operational challenges while planning scale-up:
- Limited visibility into the availability, quality consistency, and reliability of fresh lemons in the U.S. market
- Need to map the end-to-end supply chain, including domestic and international sourcing options (U.S., Mexico, Argentina)
- High dependency on agricultural commodity dynamics, creating risks from seasonality and price volatility
- Requirement to pre-qualify suppliers and mitigate supply disruption risks ahead of scale-up
- Need for a cost-effective procurement strategy aligned with regulatory, quality, and compliance standards
Kepler’s Approach
Kepler Ventures executed a structured three-month engagement combining macro-level market intelligence with supplier-level execution planning.
Phase 1: Macro Supply Chain & Market Assessment
- Market and trade analysis covering U.S. lemon production, imports, and demand dynamics
- Mapping of the lemon value chain, including growers, aggregators, processors, and distributors
- Review of regulatory and quality requirements relevant to pharmaceutical-grade sourcing
- Risk assessment covering seasonality, geographic concentration, logistics, and pricing volatility
Phase 2: Supplier Identification & Pre-Qualification
- Identification and profiling of potential lemon suppliers across the U.S., Mexico, and Argentina
- Supplier capability assessment covering scale, quality controls, consistency, and compliance readiness
- Pre-qualification framework to shortlist suppliers suitable for industrial-scale pharmaceutical use
Phase 3: Procurement Strategy & Risk Mitigation
- Development of a phased procurement roadmap aligned with production scale-up timelines
- Design of sourcing diversification and risk mitigation strategies
- Communication and change management support to align internal stakeholders
- Pre-audit readiness assessment for shortlisted suppliers
Impact & Outcome
- End-to-end U.S. lemon supply chain mapped across domestic and international sourcing routes
- Multiple suppliers identified and pre-qualified across the U.S., Mexico, and Argentina
- Supply and price risks mitigated through diversification and structured procurement planning
- Enabled industrial-scale pharmaceutical production, supporting a successful product launch
- Delivered a data-backed procurement strategy aligned with regulatory, quality, and cost requirements
